Global Pneumococcal Vaccine Market Research Report 2026(Status and Outlook)
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
The global Pneumococcal Vaccine market size was estimated at USD 7358.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 1.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pneumococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pneumococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pneumococcal Vaccine market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Pneumococcal Vaccine market size was estimated at USD 7358.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 1.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pneumococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pneumococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pneumococcal Vaccine market.
Global Pneumococcal Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
Market Segmentation (by Type)
- PPSV 23
- PCV 7/13
- PCV 10
Market Segmentation (by Application)
- Child
- Adult
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pneumococcal Vaccine Market
Overview of the regional outlook of the Pneumococcal Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pneumococcal Vaccine
1.2 Key Market Segments
1.2.1 Pneumococcal Vaccine Segment by Type
1.2.2 Pneumococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pneumococcal Vaccine Product Life Cycle
3.3 Global Pneumococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pneumococcal Vaccine Market Competitive Situation and Trends
3.8.1 Pneumococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pneumococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pneumococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Pneumococcal Vaccine Price by Type (2020-2025)
7 PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Pneumococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 PNEUMOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Pneumococcal Vaccine Sales by Region
8.1.1 Global Pneumococcal Vaccine Sales by Region
8.1.2 Global Pneumococcal Vaccine Sales Market Share by Region
8.2 Global Pneumococcal Vaccine Market Size by Region
8.2.1 Global Pneumococcal Vaccine Market Size by Region
8.2.2 Global Pneumococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pneumococcal Vaccine Sales by Country
8.3.2 North America Pneumococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pneumococcal Vaccine Sales by Country
8.4.2 Europe Pneumococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pneumococcal Vaccine Sales by Region
8.5.2 Asia Pacific Pneumococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pneumococcal Vaccine Sales by Country
8.6.2 South America Pneumococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pneumococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Pneumococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PNEUMOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pneumococcal Vaccine by Region(2020-2025)
9.2 Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal Vaccine Production
9.4.1 North America Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal Vaccine Production
9.5.1 Europe Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal Vaccine Production (2020-2025)
9.6.1 Japan Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal Vaccine Production (2020-2025)
9.7.1 China Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Pneumococcal Vaccine Product Overview
10.1.3 Pfizer Pneumococcal Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Pneumococcal Vaccine Product Overview
10.2.3 GSK Pneumococcal Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 MSD
10.3.1 MSD Basic Information
10.3.2 MSD Pneumococcal Vaccine Product Overview
10.3.3 MSD Pneumococcal Vaccine Product Market Performance
10.3.4 MSD Business Overview
10.3.5 MSD SWOT Analysis
10.3.6 MSD Recent Developments
10.4 Sanofipasteur
10.4.1 Sanofipasteur Basic Information
10.4.2 Sanofipasteur Pneumococcal Vaccine Product Overview
10.4.3 Sanofipasteur Pneumococcal Vaccine Product Market Performance
10.4.4 Sanofipasteur Business Overview
10.4.5 Sanofipasteur Recent Developments
10.5 CDIBP
10.5.1 CDIBP Basic Information
10.5.2 CDIBP Pneumococcal Vaccine Product Overview
10.5.3 CDIBP Pneumococcal Vaccine Product Market Performance
10.5.4 CDIBP Business Overview
10.5.5 CDIBP Recent Developments
11 PNEUMOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Pneumococcal Vaccine Market Size Forecast
11.2 Global Pneumococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pneumococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pneumococcal Vaccine Market Size Forecast by Region
11.2.4 South America Pneumococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pneumococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pneumococcal Vaccine by Type (2026-2035)
12.1.2 Global Pneumococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pneumococcal Vaccine by Type (2026-2035)
12.2 Global Pneumococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pneumococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pneumococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pneumococcal Vaccine
1.2 Key Market Segments
1.2.1 Pneumococcal Vaccine Segment by Type
1.2.2 Pneumococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pneumococcal Vaccine Product Life Cycle
3.3 Global Pneumococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pneumococcal Vaccine Market Competitive Situation and Trends
3.8.1 Pneumococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pneumococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pneumococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Pneumococcal Vaccine Price by Type (2020-2025)
7 PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Pneumococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 PNEUMOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Pneumococcal Vaccine Sales by Region
8.1.1 Global Pneumococcal Vaccine Sales by Region
8.1.2 Global Pneumococcal Vaccine Sales Market Share by Region
8.2 Global Pneumococcal Vaccine Market Size by Region
8.2.1 Global Pneumococcal Vaccine Market Size by Region
8.2.2 Global Pneumococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pneumococcal Vaccine Sales by Country
8.3.2 North America Pneumococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pneumococcal Vaccine Sales by Country
8.4.2 Europe Pneumococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pneumococcal Vaccine Sales by Region
8.5.2 Asia Pacific Pneumococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pneumococcal Vaccine Sales by Country
8.6.2 South America Pneumococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pneumococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Pneumococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PNEUMOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pneumococcal Vaccine by Region(2020-2025)
9.2 Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal Vaccine Production
9.4.1 North America Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal Vaccine Production
9.5.1 Europe Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal Vaccine Production (2020-2025)
9.6.1 Japan Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal Vaccine Production (2020-2025)
9.7.1 China Pneumococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Pneumococcal Vaccine Product Overview
10.1.3 Pfizer Pneumococcal Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Pneumococcal Vaccine Product Overview
10.2.3 GSK Pneumococcal Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 MSD
10.3.1 MSD Basic Information
10.3.2 MSD Pneumococcal Vaccine Product Overview
10.3.3 MSD Pneumococcal Vaccine Product Market Performance
10.3.4 MSD Business Overview
10.3.5 MSD SWOT Analysis
10.3.6 MSD Recent Developments
10.4 Sanofipasteur
10.4.1 Sanofipasteur Basic Information
10.4.2 Sanofipasteur Pneumococcal Vaccine Product Overview
10.4.3 Sanofipasteur Pneumococcal Vaccine Product Market Performance
10.4.4 Sanofipasteur Business Overview
10.4.5 Sanofipasteur Recent Developments
10.5 CDIBP
10.5.1 CDIBP Basic Information
10.5.2 CDIBP Pneumococcal Vaccine Product Overview
10.5.3 CDIBP Pneumococcal Vaccine Product Market Performance
10.5.4 CDIBP Business Overview
10.5.5 CDIBP Recent Developments
11 PNEUMOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Pneumococcal Vaccine Market Size Forecast
11.2 Global Pneumococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pneumococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pneumococcal Vaccine Market Size Forecast by Region
11.2.4 South America Pneumococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pneumococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pneumococcal Vaccine by Type (2026-2035)
12.1.2 Global Pneumococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pneumococcal Vaccine by Type (2026-2035)
12.2 Global Pneumococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pneumococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pneumococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pneumococcal Vaccine Market Size by Type (M USD)
Table 4. Global Pneumococcal Vaccine Market Size by Application
Table 5. Pneumococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pneumococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2025)
Table 11. Global Market Pneumococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pneumococcal Vaccine Sales by Type (K MT)
Table 27. Global Pneumococcal Vaccine Market Size by Type (M USD)
Table 28. Global Pneumococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pneumococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pneumococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Pneumococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pneumococcal Vaccine Sales (K MT) by Application
Table 34. Global Pneumococcal Vaccine Market Size by Application
Table 35. Global Pneumococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pneumococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pneumococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pneumococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pneumococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pneumococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Pneumococcal Vaccine Product Overview
Table 64. Pfizer Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Pneumococcal Vaccine Product Overview
Table 70. GSK Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. MSD Basic Information
Table 75. MSD Pneumococcal Vaccine Product Overview
Table 76. MSD Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. MSD Business Overview
Table 78. MSD SWOT Analysis
Table 79. MSD Recent Developments
Table 80. Sanofipasteur Basic Information
Table 81. Sanofipasteur Pneumococcal Vaccine Product Overview
Table 82. Sanofipasteur Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofipasteur Business Overview
Table 84. Sanofipasteur Recent Developments
Table 85. CDIBP Basic Information
Table 86. CDIBP Pneumococcal Vaccine Product Overview
Table 87. CDIBP Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. CDIBP Business Overview
Table 89. CDIBP Recent Developments
Table 90. Global Pneumococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Pneumococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Pneumococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Pneumococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Pneumococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Pneumococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Pneumococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Pneumococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Pneumococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pneumococcal Vaccine Market Size by Type (M USD)
Table 4. Global Pneumococcal Vaccine Market Size by Application
Table 5. Pneumococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pneumococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2025)
Table 11. Global Market Pneumococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pneumococcal Vaccine Sales by Type (K MT)
Table 27. Global Pneumococcal Vaccine Market Size by Type (M USD)
Table 28. Global Pneumococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pneumococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pneumococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Pneumococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pneumococcal Vaccine Sales (K MT) by Application
Table 34. Global Pneumococcal Vaccine Market Size by Application
Table 35. Global Pneumococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pneumococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pneumococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pneumococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pneumococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pneumococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Pneumococcal Vaccine Product Overview
Table 64. Pfizer Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Pneumococcal Vaccine Product Overview
Table 70. GSK Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. MSD Basic Information
Table 75. MSD Pneumococcal Vaccine Product Overview
Table 76. MSD Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. MSD Business Overview
Table 78. MSD SWOT Analysis
Table 79. MSD Recent Developments
Table 80. Sanofipasteur Basic Information
Table 81. Sanofipasteur Pneumococcal Vaccine Product Overview
Table 82. Sanofipasteur Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofipasteur Business Overview
Table 84. Sanofipasteur Recent Developments
Table 85. CDIBP Basic Information
Table 86. CDIBP Pneumococcal Vaccine Product Overview
Table 87. CDIBP Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. CDIBP Business Overview
Table 89. CDIBP Recent Developments
Table 90. Global Pneumococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Pneumococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Pneumococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Pneumococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Pneumococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Pneumococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Pneumococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Pneumococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Pneumococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pneumococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pneumococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal Vaccine Product Life Cycle
Figure 13. Pneumococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pneumococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pneumococcal Vaccine
Figure 19. Global Pneumococcal Vaccine Market PEST Analysis
Figure 20. Global Pneumococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Pneumococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal Vaccine by Type in 2025
Figure 29. Market Share of Pneumococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Pneumococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal Vaccine Market Share by Application
Figure 33. Global Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pneumococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal Vaccine Market Share by Application in 2025
Figure 37. Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal Vaccine Market Size by Region in 2024
Figure 68. China Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pneumococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pneumococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pneumococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pneumococcal Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pneumococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pneumococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pneumococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal Vaccine Product Life Cycle
Figure 13. Pneumococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pneumococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pneumococcal Vaccine
Figure 19. Global Pneumococcal Vaccine Market PEST Analysis
Figure 20. Global Pneumococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Pneumococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal Vaccine by Type in 2025
Figure 29. Market Share of Pneumococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Pneumococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal Vaccine Market Share by Application
Figure 33. Global Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pneumococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal Vaccine Market Share by Application in 2025
Figure 37. Global Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal Vaccine Market Size by Region in 2024
Figure 68. China Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pneumococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pneumococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pneumococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pneumococcal Vaccine Market Share Forecast by Application (2026-2035)
